Subgroup | No. of studies | No. of patients | HR (95% CI) | P value | Heterogeneity | Effect model | |
---|---|---|---|---|---|---|---|
I2 (%) | Ph | ||||||
Overall | 17 | 8672 | 1.66 (1.39–1.98) | < 0.001 | 53 | 0.006 | Random |
Region | |||||||
 Europe | 2 | 2476 | 1.58 (0.64–3.88) | 0.32 | 80 | 0.02 | Random |
 Asia | 15 | 6196 | 1.73 (1.52–1.96) | < 0.001 | 17 | 0.26 | Fixed |
Sample size | |||||||
 ≥ 200 | 13 | 8110 | 1.58 (1.31–1.91) | < 0.001 | 57 | 0.006 | Random |
 < 200 | 4 | 562 | 2.28 (1.49–3.28) | < 0.001 | 0 | 0.43 | Fixed |
Median age (years) | |||||||
 ≥ 70 | 5 | 1818 | 1.59 (1.25–2.03) | < 0.001 | 0 | 0.43 | Fixed |
 < 70 | 11 | 6620 | 1.62 (1.30–2.01) | < 0.001 | 60 | 0.005 | Random |
Cutoff value of NLR | |||||||
 > 2.70 | 6 | 1986 | 1.60 (1.26–2.02) | < 0.001 | 0 | 0.42 | Fixed |
 ≤ 2.70 | 11 | 6686 | 1.78 (1.53–2.07) | < 0.001 | 8 | 0.37 | Fixed |
Median time of follow-up (months) | |||||||
 ≥ 36 | 11 | 6692 | 1.77 (1.41–2.22) | < 0.001 | 61 | 0.004 | Random |
 < 36 | 5 | 1890 | 1.47 (1.16–1.87) | 0.002 | 49 | 0.10 | Fixed |
Quality of study | |||||||
 High | 16 | 8582 | 1.67 (1.39–2.01) | < 0.001 | 56 | 0.003 | Random |
 Moderate | 1 | 90 | - | - | - | - | - |